Replies to post #5511 on China Growth Stocks

[BiotechValues]

mystiq- GCHT has already booked $128M in sales.

It has not been reported in a quarterly filing yet because they are a newly formed trading entity...but the filing for their reverse merger with the SEC clearly states they've got $128M in contracts already.


CWSI made all of $19M in sales last year, and is averging about 10-15M in sales/quarter this year, which is very nice growth. But unless GCHT is outright lying to the SEC in their filings, they are blowing the doors off CWSI in sales growth and sales volume.

Also- CWSI has a LOT more than 15M shares. Fully diluted they've got MORE than GCHT in their latest filing.

If anything, CWSI is the expensive stock.